Press Releases
MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets that could lead to...
News
Fresenius Medical Care Announces Leadership Change in North America
Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced a leadership change in North America. William...
Clinical Trials
Pluristem Completes Patient Enrollment in a Large Multinational Phase II Trial in Intermittent Claudication
Pluristem Therapeutics Inc , a leading developer of placenta-based cell therapy products, today announced that it has completed enrollment of all 172 patients in a multinational...
Press Releases
Relocating and Upgrading the Open Laboratory that Promotes Open Innovation for Semiconductor Packaging Materials and Processes
Hitachi Chemical Co Ltd announces the relocation of its Open Laboratory to Kawasaki City , Kanagawa Prefecture, in order to strengthen the laboratory’s functions....
Drug Research
Maverick Therapeutics, Takeda pharma  join to drive T-cell Engagement therapeutics for cancerÂ
Maverick Therapeutics Inc , an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited announced that they have entered a collaboration to develop Maverick’s...
Clinical Trials
Visterra doses first patient in phase IIa trial for VIS410 for Influenza A
Visterra, Inc , a clinical-stage biopharmaceutical company announced that the first patient was dosed in a Phase 2a clinical trial of VIS410, a monoclonal antibody...
Clinical Trials
Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
Valeant Pharmaceuticals International, Inc. announced positive results from a second confirmatory pivotal Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
